Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis-Reference-Cited by-同舟云学术

Long-term safety of crisaborole ointment 2% in children and adults with mild to moderate atopic dermatitis

Published:2017-10 Issue:4 Volume:77 Page:641-649.e5
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Eichenfield Lawrence F.,Call Robert S.,Forsha Douglass W.,Fowler Joseph,Hebert Adelaide A.,Spellman Mary,Stein Gold Linda F.,Van Syoc Merrie,Zane Lee T.,Tschen Eduardo

Publisher

Elsevier BV

Subject

Dermatology

Reference41 articles.

1. Atopic dermatitis;Bieber;N Engl J Med,2008

2. Atopic dermatitis;Bieber;Ann Dermatol,2010

3. Guidelines of care for the management of atopic dermatitis, section 2: management and treatment of atopic dermatitis with topical therapies;Eichenfield;J Am Acad Dermatol,2014

4. Atopic dermatitis: a practice parameter update 2012;Schneider;J Allergy Clin Immunol,2013

5. Rational and ethical use of topical corticosteroids based on safety and efficacy;Rathi;Indian J Dermatol,2012

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biologic and Small Molecule Therapy in Atopic Dermatitis;Biomedicines;2024-08-13

2. Recent Advances in Phytochemical-Based Topical Applications for the Management of Eczema: A Review;International Journal of Molecular Sciences;2024-05-15

3. Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies;American Journal of Clinical Dermatology;2024-05-02

4. Efficacy and Safety of Crisaborole Ointment 2% in Chinese Patients Aged ≥ 2 Years with Mild to Moderate Atopic Dermatitis;Dermatology and Therapy;2024-05

5. Maintenance of Investigator’s Static Global Assessment Response with Once-Daily Crisaborole in Participants with Mild to Moderate Atopic Dermatitis;Dermatology and Therapy;2024-03-28